Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nevirapine in HIV Patients with Hepatic Impairment
NCT00144248Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Jun 2004; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00144248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144248.